MicroRNA-506 is up-regulated in the development of pancreatic ductal adenocarcinoma and is associated with attenuated disease progression
Abstract Background MicroRNA-506 (miR-506) has been reported to function in several tumors as a tumor suppressor gene or oncogene. However, the expression and role of miR-506 in pancreatic ductal adenocarcinoma (PDAC) remains unclear. In this study, we aimed to evaluate the phenotype of miR-506 in P...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2016-07-01
|
Series: | Chinese Journal of Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40880-016-0128-9 |
id |
doaj-9a477f776578449f86e88e9223a35494 |
---|---|
record_format |
Article |
spelling |
doaj-9a477f776578449f86e88e9223a354942020-11-25T00:15:27ZengBMCChinese Journal of Cancer1944-446X2016-07-013511710.1186/s40880-016-0128-9MicroRNA-506 is up-regulated in the development of pancreatic ductal adenocarcinoma and is associated with attenuated disease progressionRun-Fen Cheng0Jian Wang1Jing-Yi Zhang2Lin Sun3Yan-Rui Zhao4Zhi-Qiang Qiu5Bao-Cun Sun6Yan Sun7Department of Pathology, Tianjin Medical University Cancer Institute and HospitalDepartment of Pancreatic Oncology, Tianjin Medical University Cancer Institute and HospitalDepartment of Pathology, Tianjin Medical University Cancer Institute and HospitalDepartment of Pathology, Tianjin Medical University Cancer Institute and HospitalDepartment of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and HospitalDepartment of Pathology, Tianjin Medical University Cancer Institute and HospitalDepartment of Pathology, Tianjin Medical University Cancer Institute and HospitalDepartment of Pathology, Tianjin Medical University Cancer Institute and HospitalAbstract Background MicroRNA-506 (miR-506) has been reported to function in several tumors as a tumor suppressor gene or oncogene. However, the expression and role of miR-506 in pancreatic ductal adenocarcinoma (PDAC) remains unclear. In this study, we aimed to evaluate the phenotype of miR-506 in PDAC. Methods Using miRNA in situ hybridization, we examined the expression of miR-506 in 113 PDACs and 87 paired normal pancreatic tissues. We evaluated miR-506 expression in PDAC cells, normal pancreatic ducts, and acinus/islands, and we analyzed the associations between miR-506 expression and the clinicopathologic characteristics of PDAC patients. Results miR-506 expression was higher in PDAC than in matched normal pancreatic ductal cells (P < 0.001). On the other hand, the combined group of well and moderately differentiated PDACs showed higher levels of miR-506 than the poorly differentiated ones (P = 0.023). Moreover, miR-506 expression was negatively associated with pathologic T category (P = 0.004) and lymph node metastasis (P = 0.033), suggesting that miR-506 might inhibit the progression of PDAC. Conclusions Our results suggest that miR-506 either plays a role as an oncogene in the tumorigenesis and a tumor suppressor in the progression or serves as a house-keeping, tumor-suppressing miRNA, whose expression can be activated by oncogenic signals in early development to hinder the progression of PDAC.http://link.springer.com/article/10.1186/s40880-016-0128-9Pancreatic ductal adenocarcinomamiR-506Tumor suppressorDevelopmentProgression |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Run-Fen Cheng Jian Wang Jing-Yi Zhang Lin Sun Yan-Rui Zhao Zhi-Qiang Qiu Bao-Cun Sun Yan Sun |
spellingShingle |
Run-Fen Cheng Jian Wang Jing-Yi Zhang Lin Sun Yan-Rui Zhao Zhi-Qiang Qiu Bao-Cun Sun Yan Sun MicroRNA-506 is up-regulated in the development of pancreatic ductal adenocarcinoma and is associated with attenuated disease progression Chinese Journal of Cancer Pancreatic ductal adenocarcinoma miR-506 Tumor suppressor Development Progression |
author_facet |
Run-Fen Cheng Jian Wang Jing-Yi Zhang Lin Sun Yan-Rui Zhao Zhi-Qiang Qiu Bao-Cun Sun Yan Sun |
author_sort |
Run-Fen Cheng |
title |
MicroRNA-506 is up-regulated in the development of pancreatic ductal adenocarcinoma and is associated with attenuated disease progression |
title_short |
MicroRNA-506 is up-regulated in the development of pancreatic ductal adenocarcinoma and is associated with attenuated disease progression |
title_full |
MicroRNA-506 is up-regulated in the development of pancreatic ductal adenocarcinoma and is associated with attenuated disease progression |
title_fullStr |
MicroRNA-506 is up-regulated in the development of pancreatic ductal adenocarcinoma and is associated with attenuated disease progression |
title_full_unstemmed |
MicroRNA-506 is up-regulated in the development of pancreatic ductal adenocarcinoma and is associated with attenuated disease progression |
title_sort |
microrna-506 is up-regulated in the development of pancreatic ductal adenocarcinoma and is associated with attenuated disease progression |
publisher |
BMC |
series |
Chinese Journal of Cancer |
issn |
1944-446X |
publishDate |
2016-07-01 |
description |
Abstract Background MicroRNA-506 (miR-506) has been reported to function in several tumors as a tumor suppressor gene or oncogene. However, the expression and role of miR-506 in pancreatic ductal adenocarcinoma (PDAC) remains unclear. In this study, we aimed to evaluate the phenotype of miR-506 in PDAC. Methods Using miRNA in situ hybridization, we examined the expression of miR-506 in 113 PDACs and 87 paired normal pancreatic tissues. We evaluated miR-506 expression in PDAC cells, normal pancreatic ducts, and acinus/islands, and we analyzed the associations between miR-506 expression and the clinicopathologic characteristics of PDAC patients. Results miR-506 expression was higher in PDAC than in matched normal pancreatic ductal cells (P < 0.001). On the other hand, the combined group of well and moderately differentiated PDACs showed higher levels of miR-506 than the poorly differentiated ones (P = 0.023). Moreover, miR-506 expression was negatively associated with pathologic T category (P = 0.004) and lymph node metastasis (P = 0.033), suggesting that miR-506 might inhibit the progression of PDAC. Conclusions Our results suggest that miR-506 either plays a role as an oncogene in the tumorigenesis and a tumor suppressor in the progression or serves as a house-keeping, tumor-suppressing miRNA, whose expression can be activated by oncogenic signals in early development to hinder the progression of PDAC. |
topic |
Pancreatic ductal adenocarcinoma miR-506 Tumor suppressor Development Progression |
url |
http://link.springer.com/article/10.1186/s40880-016-0128-9 |
work_keys_str_mv |
AT runfencheng microrna506isupregulatedinthedevelopmentofpancreaticductaladenocarcinomaandisassociatedwithattenuateddiseaseprogression AT jianwang microrna506isupregulatedinthedevelopmentofpancreaticductaladenocarcinomaandisassociatedwithattenuateddiseaseprogression AT jingyizhang microrna506isupregulatedinthedevelopmentofpancreaticductaladenocarcinomaandisassociatedwithattenuateddiseaseprogression AT linsun microrna506isupregulatedinthedevelopmentofpancreaticductaladenocarcinomaandisassociatedwithattenuateddiseaseprogression AT yanruizhao microrna506isupregulatedinthedevelopmentofpancreaticductaladenocarcinomaandisassociatedwithattenuateddiseaseprogression AT zhiqiangqiu microrna506isupregulatedinthedevelopmentofpancreaticductaladenocarcinomaandisassociatedwithattenuateddiseaseprogression AT baocunsun microrna506isupregulatedinthedevelopmentofpancreaticductaladenocarcinomaandisassociatedwithattenuateddiseaseprogression AT yansun microrna506isupregulatedinthedevelopmentofpancreaticductaladenocarcinomaandisassociatedwithattenuateddiseaseprogression |
_version_ |
1725386757757730816 |